Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion type Assertion NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_head.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion evidence source_evidence_literature NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion SIO_000772 21047409 NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion wasDerivedFrom befree-20150227 NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.
- NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion wasGeneratedBy ECO_0000203 NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.